🇺🇸 Finerenone Oral Tablet in United States

FDA authorised Finerenone Oral Tablet on 9 July 2021

Marketing authorisations

FDA — authorised 9 July 2021

  • Application: NDA215341
  • Marketing authorisation holder: BAYER HLTHCARE
  • Local brand name: KERENDIA
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Finerenone Oral Tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Finerenone Oral Tablet approved in United States?

Yes. FDA authorised it on 9 July 2021; FDA has authorised it.

Who is the marketing authorisation holder for Finerenone Oral Tablet in United States?

BAYER HLTHCARE holds the US marketing authorisation.